Division of Molecular Immunology Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; Department of Medical Biology, University of Melbourne, Melbourne, Australia;
Peter MacCallum Cancer Centre, Melbourne, Australia; and.
Blood. 2014 May 29;123(22):3420-8. doi: 10.1182/blood-2014-03-561456. Epub 2014 Apr 10.
Interleukin-10 (IL-10) is a key immunoregulatory cytokine that functions to prevent inflammatory and autoimmune diseases. Despite the critical role for IL-10 produced by effector CD8(+) T cells during pathogen infection and autoimmunity, the mechanisms regulating its production are poorly understood. We show that loss of the inhibitor of DNA binding 2 (Id2) in T cells resulted in aberrant IL-10 expression in vitro and in vivo during influenza virus infection and in a model of acute graft-versus-host disease (GVHD). Furthermore, IL-10 overproduction substantially reduced the immunopathology associated with GVHD. We demonstrate that Id2 acts to repress the E2A-mediated trans-activation of the Il10 locus. Collectively, our findings uncover a key regulatory role of Id2 during effector T cell differentiation necessary to limit IL-10 production by activated T cells and minimize their suppressive activity during the effector phase of disease control.
白细胞介素-10(IL-10)是一种关键的免疫调节细胞因子,其功能是预防炎症和自身免疫性疾病。尽管效应 CD8(+) T 细胞在病原体感染和自身免疫中产生的 IL-10 起着至关重要的作用,但调节其产生的机制仍知之甚少。我们发现,T 细胞中 DNA 结合抑制因子 2(Id2)的缺失导致流感病毒感染期间和急性移植物抗宿主病(GVHD)模型中体外和体内的 IL-10 表达异常。此外,IL-10 的过度产生大大减轻了与 GVHD 相关的免疫病理学。我们证明 Id2 作用于抑制 E2A 介导的 Il10 基因座的转激活。总之,我们的研究结果揭示了 Id2 在效应 T 细胞分化过程中的关键调节作用,这对于限制激活的 T 细胞产生 IL-10 并在疾病控制的效应阶段最小化其抑制活性是必要的。